- Home
- CSGS vs XNCR Comparison
CSGS vs XNCR Comparison
Compare CSGS & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGS
- XNCR
- Stock Information
- Founded
- CSGS 1994
- XNCR 1997
- Country
- CSGS United States
- XNCR United States
- Employees
- CSGS N/A
- XNCR N/A
- Industry
- CSGS EDP Services
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- CSGS Technology
- XNCR Health Care
- Exchange
- CSGS Nasdaq
- XNCR Nasdaq
- Market Cap
- CSGS 1.6B
- XNCR 1.5B
- IPO Year
- CSGS 1996
- XNCR 2013
- Fundamental
- Price
- CSGS $53.57
- XNCR $25.04
- Analyst Decision
- CSGS Buy
- XNCR Strong Buy
- Analyst Count
- CSGS 4
- XNCR 9
- Target Price
- CSGS $62.00
- XNCR $36.33
- AVG Volume (30 Days)
- CSGS 192.8K
- XNCR 627.6K
- Earning Date
- CSGS 02-05-2025
- XNCR 11-06-2024
- Dividend Yield
- CSGS 2.24%
- XNCR N/A
- EPS Growth
- CSGS N/A
- XNCR N/A
- EPS
- CSGS 2.27
- XNCR N/A
- Revenue
- CSGS $1,177,920,000.00
- XNCR $85,164,000.00
- Revenue This Year
- CSGS $3.57
- XNCR N/A
- Revenue Next Year
- CSGS $2.89
- XNCR $89.22
- P/E Ratio
- CSGS $23.77
- XNCR N/A
- Revenue Growth
- CSGS 1.39
- XNCR N/A
- 52 Week Low
- CSGS $39.56
- XNCR $15.31
- 52 Week High
- CSGS $57.16
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- CSGS 49.26
- XNCR 55.45
- Support Level
- CSGS $53.15
- XNCR $23.78
- Resistance Level
- CSGS $54.86
- XNCR $26.59
- Average True Range (ATR)
- CSGS 1.04
- XNCR 1.00
- MACD
- CSGS -0.34
- XNCR -0.26
- Stochastic Oscillator
- CSGS 21.65
- XNCR 36.42
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from Americas (principally the U.S.).
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.